-
FDA Pulls Authorization for Evusheld, Says It’s Ineffective Against New COVID Mutations -
AstraZeneca’s COVID-19 Prevention Drug Granted Emergency Authorization for Immune Compromised -
FDA Grants Eli Lilly’s Experimental COVID-19 Antibody-Drug Emergency Use Authorization -
US to Pay Eli Lilly $375 Million for 300,000 Vials of Experimental COVID-19 Antibody Drug